Harte Hanks (HHS) Common Equity (2010 - 2026)

Harte Hanks (HHS) has 17 years of Common Equity data on file, last reported at $20.1 million in Q1 2026.

• Common Equity for Q1 2026 came in at $20.1 million, down 6.15% year-over-year; the trailing twelve-month figure through Mar 2026 was $20.1 million (down 6.15% YoY), and the FY2025 annual result was $20.5 million, down 5.36% from the prior year.
• Common Equity eased to $20.1 million in Q1 2026 per HHS's latest filing, from $20.5 million in the prior quarter.
• Over five years, Common Equity peaked at $22.2 million in Q2 2025 and troughed at -$20.6 million in Q1 2022.
• A 5-year average of $13.9 million and a median of $20.5 million in 2023 frame the typical range for Common Equity.
• The sharpest annual moves came in 2023 and 2026: Common Equity surged 260.33% in 2023, then declined 6.15% in 2026.
• A 5-year view of Common Equity shows it stood at $18.8 million in 2022, then advanced by 5.58% to $19.9 million in 2023, then grew by 9.23% to $21.7 million in 2024, then decreased by 5.36% to $20.5 million in 2025, then dropped by 2.06% to $20.1 million in 2026.
• Business Quant data shows HHS's Common Equity at $20.1 million in Q1 2026, $20.5 million in Q4 2025, and $19.9 million in Q3 2025.